NBBK Stock Analysis: NB Bancorp, Common Stock | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 957m USD | 12M Return: 17.3% | US63945M1071 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.57M
Qual. Beats: 0
Rev. Trend: 96.4%
Qual. Beats: 3
Warnings
Tailwinds
No distinct edge detected
Seasonality 2.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
NB Bancorp, Inc. (NASDAQ: NBBK) operates as the bank holding company for Needham Bank, a community bank founded in 1892 and headquartered in Needham, Massachusetts. The company serves the Greater Boston metropolitan area and surrounding communities, offering a full range of deposit products (including checking, savings, money market, NOW, and CDs) and a diversified loan portfolio spanning commercial real estate, multifamily and one- to four-family residential mortgages, mortgage warehouse lending, construction and land development, commercial and industrial, consumer, and home equity products. NB Bancorp also maintains an investment securities portfolio composed primarily of U.S. Treasury, federal agency, government-sponsored residential mortgage-backed, corporate, SBA, and municipal bonds.
As a recently public regional bank (IPOd in late 2023), NB Bancorp operates under the standard bank holding company structure, where the parent company owns the operating bank and is subject to Federal Reserve oversight while the subsidiary bank is regulated by the OCC and FDIC. Community-oriented lenders like Needham Bank typically rely on local deposit gathering and relationship-based commercial lending, with a meaningful allocation to commercial real estate loans being a common feature of the regional bank business model in the Northeast.
- Net interest margin compression as Fed cuts rates
- Commercial real estate loan portfolio faces regional bank stress
- Deposit growth in Greater Boston market supports funding costs
| Net Income: 66.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.11 > 1.0 |
| NWC/Revenue: -1.41k% < 20% (prev -1.30k%; Δ -113.3% < -1%) |
| CFO/TA 0.02 > 3% & CFO 131.3m > Net Income 66.9m |
| Net Debt (-395.3m) to EBITDA (98.7m): -4.00 < 3 |
| Current Ratio: 0.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (39.8m) vs 12m ago 11.96% < -2% |
| Gross Margin: 57.78% > 18% (prev 56.85%; Δ 0.92% > 0.5%) |
| Asset Turnover: 6.37% > 50% (prev 6.03%; Δ 0.34% > 0%) |
| Interest Coverage Ratio: 0.55 > 6 (EBIT TTM 91.7m / Interest Expense TTM 166.8m) |
| A: -0.77 (Total Current Assets 631.5m - Total Current Liabilities 6.53b) / Total Assets 7.68b |
| B: 0.06 (Retained Earnings 495.1m / Total Assets 7.68b) |
| C: 0.01 (EBIT TTM 91.7m / Avg Total Assets 6.56b) |
| D: 0.13 (Book Value of Equity 857.4m / Total Liabilities 6.83b) |
| Altman-Z'' = -4.60 = D |
| DSRI: 1.12 (Receivables 30.0m/21.1m, Revenue 418.0m/327.9m) |
| GMI: 0.98 (GM 56.85% / 57.78%) |
| AQI: 0.97 (AQ_t 0.91 / AQ_t-1 0.94) |
| SGI: 1.27 (Revenue 418.0m / 327.9m) |
| TATA: -0.01 (NI 66.9m - CFO 131.3m) / TA 7.68b) |
| Beneish M = -2.76 (Cap -4..+1) = A |
As of November 20, 2026, the stock is trading at USD 21.14 with a total of 212,130 shares traded. Over the past week, the price has changed by -3.51%, over one month by -1.32%, over three months by -3.17% and over the past year by +17.26%.
Current recommended Stop Loss: 20.00 (which is 5.4% or 2 ATR below the current price).
NB Bancorp, Common Stock has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold NBBK.
- StrongBuy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 25 | 18.3% |
P/E Trailing = 13.0778
P/S = 3.496
P/B = 1.1179
Revenue TTM = 418.0m USD
EBIT TTM = 91.7m USD
EBITDA TTM = 98.7m USD
Long Term Debt = 150.3m USD (from longTermDebt, last quarter)
Short Term Debt = 169.0m USD (from shortLongTermDebt, last fiscal year)
Debt = 150.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -395.3m USD (calculated: Debt 150.3m - CCE 545.6m)
Enterprise Value = 561.7m USD (957.0m + Debt 150.3m - CCE 545.6m)
Interest Coverage Ratio = 0.55 (Ebit TTM 91.7m / Interest Expense TTM 166.8m)
EV/FCF = 4.63x (Enterprise Value 561.7m / FCF TTM 121.3m)
FCF Yield = 21.60% (FCF TTM 121.3m / Enterprise Value 561.7m)
FCF Margin = 29.02% (FCF TTM 121.3m / Revenue TTM 418.0m)
Net Margin = 16.01% (Net Income TTM 66.9m / Revenue TTM 418.0m)
Gross Margin = 57.78% ((Revenue TTM 418.0m - Cost of Revenue TTM 176.5m) / Revenue TTM)
Gross Margin QoQ = 62.10% (prev 60.94%)
Tobins Q-Ratio = 0.07 (Enterprise Value 561.7m / Total Assets 7.68b)
Interest Expense / Debt = 111.0% (Interest Expense 166.8m / Debt 150.3m)
Taxrate = 27.03% (24.8m / 91.7m)
NOPAT = 66.9m (EBIT 91.7m * (1 - 27.03%))
Current Ratio = 0.10 (Total Current Assets 631.5m / Total Current Liabilities 6.53b)
Debt / Equity = 0.18 (Debt 150.3m / totalStockholderEquity, last quarter 857.4m)
Debt / EBITDA = -4.00 (Net Debt -395.3m / EBITDA 98.7m)
Debt / FCF = -3.26 (Net Debt -395.3m / FCF TTM 121.3m)
Total Stockholder Equity = 850.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.02% (Net Income 66.9m / Total Assets 7.68b)
RoE = 7.87% (Net Income TTM 66.9m / Total Stockholder Equity 850.3m)
RoCE = 9.17% (EBIT 91.7m / Capital Employed (Equity 850.3m + L.T.Debt 150.3m))
RoIC = 5.89% (NOPAT 66.9m / Invested Capital 1.14b)
WACC = 6.45% (E(957.0m)/V(1.11b) * Re(7.46%) + (debt cost/tax rate unavailable))
Discount Rate = 7.46% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 35.47 | Cagr: 0.61%
[DCF] Terminal Value 77.97% ; FCFF base≈104.7m ; Y1≈120.0m ; Y5≈176.6m
[DCF] Fair Price = 69.67 (EV 2.66b - Net Debt -395.3m = Equity 3.05b / Shares 43.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.14 | # QB: 0
Revenue Correlation: 96.37 | Revenue CAGR: 18.35% | SUE: 2.12 | # QB: 3
EPS current Quarter (2027-03-31): EPS=0.56 | Chg30d=-4.24% | Revisions=-25% | Analysts=2
EPS current Year (2026-12-31): EPS=2.08 | Chg30d=-2.58% | Revisions=-25% | GrowthEPS=+21.6% | GrowthRev=+39.7%
EPS next Year (2027-12-31): EPS=2.51 | Chg30d=-3.65% | Revisions=+0% | GrowthEPS=+20.7% | GrowthRev=+9.8%
[Analyst] Revisions Ratio: -29% (up=1, down=3)